Skip to main content
BGI Genomics Co., Ltd. logo

BGI Genomics Co., Ltd. — Investor Relations & Filings

Ticker · 300676 ISIN · CNE100003449 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 1,655 across all filing types
Latest filing 2021-11-26 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300676

About BGI Genomics Co., Ltd.

https://www.bgi.com

BGI Genomics Co., Ltd. is a leading provider of integrated solutions for precision medicine, specializing in genomic sequencing and proteomic services. The company offers a comprehensive portfolio of clinical diagnostics and research services across various fields, including reproductive health, oncology, and infectious diseases. Key products include non-invasive prenatal testing, hereditary cancer screening, and pathogen identification tools. Leveraging proprietary DNBseq sequencing technology, BGI Genomics provides high-throughput, cost-effective genomic data analysis to healthcare providers, research institutions, and pharmaceutical companies worldwide. The organization focuses on advancing personalized medicine through large-scale genomic research and the development of innovative diagnostic applications, aiming to improve health outcomes by making advanced genetic insights accessible to a global population.

Recent filings

Filing Released Lang Actions
关于控股子公司产品获得英国MHRA注册的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shenzhen BGI Genomics Co., Ltd. regarding a product of its controlling subsidiary obtaining registration approval from the UK's MHRA (Medicines & Healthcare products Regulatory Agency). It details the product information, market context, and potential impact on the company. The document is short (1360 characters) and does not contain financial statements or detailed financial data. It is an announcement about a regulatory approval event rather than a financial report or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-11-26 Chinese
关于参加2021深圳辖区上市公司投资者网上集体接待日活动的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (544 characters) about the company's participation in an investor online collective reception day event. It mentions the date and the platform for investor communication but does not contain any financial data, report, or detailed presentation. It is not a report itself but an announcement of an event related to investor relations. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-11-23 Chinese
关于回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement regarding the progress of a share repurchase plan by the company Shenzhen Huada Gene Co., Ltd. It details the board's approval of the share buyback plan, the funding limits, price limits, and the timeline for the repurchase. It explicitly states that as of the announcement date, no shares have been repurchased yet, and it commits to further disclosures as the repurchase progresses. This is a typical format for a Transaction in Own Shares (POS) filing, which reports on share buyback activities. The document is not a full financial report, earnings release, or regulatory certification, but a specific update on share repurchase progress.
2021-11-03 Chinese
关于以集中竞价方式回购公司股份的回购报告书
Transaction in Own Shares Classification · 98% confidence The document is a detailed announcement from Shenzhen BGI Genomics Co., Ltd. regarding a share repurchase plan using centralized bidding. It includes specifics about the repurchase purpose, amount, price limits, procedures, funding sources, impact analysis on financials and operations, risk disclosures, and authorization details. The document is lengthy (over 10,000 characters) and contains substantive information about the share buyback program, including quantitative data and management analysis. It is not a brief announcement of a report publication, nor is it a certification or a general regulatory filing. The content clearly matches the definition of a Transaction in Own Shares (POS) filing, which covers company buyback or sale of its own shares. Therefore, the appropriate classification is POS with high confidence.
2021-11-01 Chinese
关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告
Transaction in Own Shares Classification · 100% confidence The document is an announcement from Shenzhen BGI Genomics Co., Ltd. regarding the shareholding status of the top ten shareholders and top ten unrestricted shareholders as of October 28, 2021, prior to a share repurchase plan approved on October 27, 2021. It references a share repurchase plan and provides detailed shareholding data but does not contain financial statements or earnings data. The content focuses on shareholding information related to a share buyback event. This fits the category of a Transaction in Own Shares (POS) filing, which reports on the company's buyback or sale of its own shares.
2021-10-29 Chinese
关于全资子公司无创产前基因检测相关产品获得印度进口许可证的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Shenzhen BGI Genomics Co., Ltd. regarding its wholly-owned subsidiary obtaining an import license for non-invasive prenatal genetic testing products in India. It details product information, market context, and potential impact on the company. There are no financial statements, no quarterly or annual report data, no earnings highlights, no management discussion of financial results, nor any regulatory certifications or voting results. The document is relatively short (2057 characters) and serves as a regulatory announcement about a product approval and market entry. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-10-28 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.